S Borgsteede, R Bruggeman, R Hoefnagel, M Huiskes, E van Puijenbroek. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » Adrenergic alpha-Antagonists/adverse effectsAdrenergic alpha-Antagonists/therapeutic useAgedBlood Glucose/metabolismDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/drug therapyDrug InteractionsHumansHyperglycemia/chemically inducedHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useInsulin/adverse effectsInsulin/therapeutic useMaleMiddle AgedSulfonamides/adverse effectsSulfonamides/therapeutic useTamsulosin
Substances： See more » Adrenergic alpha-AntagonistsBlood GlucoseHypoglycemic AgentsInsulinSulfonamidesTamsulosin
Year: 2010 PMID： 20308713
Source DB: PubMed Journal: Neth J Med ISSN： 0300-2977 Impact factor: 1.422